Bihari Shailesh, Holt Andrew W, Prakash Shivesh, Bersten Andrew D
Department of ICCU, Flinders Medical Centre, South Australia, 5042; Department of Critical Care Medicine, Flinders University, South Australia, 5042.
J Crit Care. 2016 Jun;33:200-6. doi: 10.1016/j.jcrc.2016.01.017. Epub 2016 Jan 27.
Fluid and sodium overload are a common problem in critically ill patients. Frusemide may result in diuresis in excess of natriuresis. The addition of indapamide may achieve a greater natriuresis, and also circumvent some of the problems associated with frusemide. The objective of this study was to examine the effect of adding indapamide to frusemide on diuresis, natriuresis, creatinine clearance and serum electrolytes.
Fluid overloaded ICU patients were randomised to either intravenous frusemide (Group F) or intravenous frusemide and enteral indapamide (Group F + I). Comprehensive exclusion criteria were applied to address confounders. 24 hour urine was analysed for electrolytes and creatinine. Serum electrolytes were measured before and 24 hours after administration of diuretics.
Forty patients (20 in each group) were included in the study. The groups were similar in their baseline characteristics. Over the 24 h study period, patients in Group F + I, had a larger natriuresis (P = 0.01), chloride loss (P = 0.01) and kaliuresis (P = 0.047). Patients in Group F + I also had a greater 24 hour urinary creatinine clearance (P = 0.01). The 24 hour urine volume and fluid balance was similar between the groups. Patients in Group F had an increase in serum sodium (P = 0.04), while patients in Group F + I had a decrease in both serum chloride (P = 0.01) and peripheral oedema (P < 0.001) during the study duration.
In fluid overloaded ICU patients, addition of indapamide to frusemide led to a greater natriuresis and creatinine clearance. Such a strategy might be utilised in optimising sodium balance in ICU patients.
液体和钠超负荷是重症患者常见的问题。呋塞米可能导致利尿超过排钠。加用吲达帕胺可能会实现更大的排钠效果,并且还能规避一些与呋塞米相关的问题。本研究的目的是探讨在呋塞米基础上加用吲达帕胺对利尿、排钠、肌酐清除率和血清电解质的影响。
液体超负荷的重症监护病房(ICU)患者被随机分为静脉注射呋塞米组(F组)或静脉注射呋塞米加肠内给予吲达帕胺组(F + I组)。应用全面的排除标准以解决混杂因素。对24小时尿液进行电解质和肌酐分析。在给予利尿剂前及给药后24小时测量血清电解质。
该研究纳入了40例患者(每组20例)。两组的基线特征相似。在24小时研究期间,F + I组患者有更大的排钠量(P = 0.01)、氯丢失量(P = 0.01)和钾排出量(P = 0.047)。F + I组患者24小时尿肌酐清除率也更高(P = 0.01)。两组间24小时尿量和液体平衡相似。在研究期间,F组患者血清钠升高(P = 0.04),而F + I组患者血清氯降低(P = 0.01)且外周水肿减轻(P < 0.001)。
在液体超负荷的ICU患者中,在呋塞米基础上加用吲达帕胺可导致更大的排钠量和肌酐清除率。这种策略可用于优化ICU患者的钠平衡。